Hanmi Pharm engages in developing and marketing biological drugs for diabetes and metabolic diseases.
Business Model:
Revenue: $980.6M
Employees: 1,001-5,000
Address: 14, Wiryeseong-daero
City: Songpa-gu
State: seoul teugbyeolsi
Zip: 138-724
Country: KR
Hanmi Pharm engages in developing and marketing biological drugs for diabetes and metabolic diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Korea Exchange
Ticker Symbol:
Hanmi Pharm. (128940)
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2022 | Spectrum Pharmaceuticals | Post-IPO Equity | 0 |
1/2015 | Allegro Ophthalmics | Series C | 0 |
4/2022 | Digital Pharm | Corporate Round | - |
10/2017 | Darmiyan | Seed Round | 0 |
4/2022 | Digital Pharm | Corporate Round | - |
1/2022 | Spectrum Pharmaceuticals | Post-IPO Equity | 0 |
10/2017 | Darmiyan | Seed Round | 0 |
1/2015 | Allegro Ophthalmics | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|